Literature DB >> 19205732

A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis.

Stefanie Wildi-Runge1, Simone Allemann, Urs B Schaad, Ulrich Heininger.   

Abstract

Rotavirus (RV) is a frequent cause of severe gastroenteritis (GE) in children. With the licensure of new RV vaccines, data on the burden of disease are important regarding immunization strategies. We reviewed the medical records of children hospitalized with RV infection in our institution between July 2002 and March 2006. Relevant data were extracted in a standardized fashion from records of hospitalized children with a positive RV antigen test in a stool sample. Severity of disease was graded by the 20-point Vesikari score. Population data were obtained from the Federal Office of Statistics. Six hundred eighty-six RVGE were identified and records of 608 hospitalizations (in 607 children) were available. In 539 (89%) cases, RVGE was the primary reason for hospitalization and 69 (11%) were nosocomial infections; yearly peaks occurred between February and May. Cumulative incidence of RVGE was 26.7/1,000 children <3 years of age. Median age of 539 children (55.6% male) with primary RVGE was 1.4 years and median stay in the hospital for both community acquired and nosocomial RVGE was 4 days (interquartile range 3-5). Thirtypercent and 94% of RV hospitalizations were in children <1 and <3 years of age, respectively. Mean Vesikari score was 15 (range 6-20; 96% >11). Intravenous fluids were administered in 378 (70%) patients, 130 (24%) patients were rehydrated via nasogastral tube, and 31 (5.7%) received rehydration by mouth. RVGE causes a substantial burden in children with an estimated risk for hospitalization due to RVGE of one in 37 children <3 years of age.

Entities:  

Mesh:

Year:  2009        PMID: 19205732     DOI: 10.1007/s00431-009-0934-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  33 in total

1.  Rotavirus in Ireland: national estimates of disease burden, 1997 to 1998.

Authors:  M Lynch; F O'Halloran; D Whyte; S Fanning; B Cryan; R I Glass
Journal:  Pediatr Infect Dis J       Date:  2001-07       Impact factor: 2.129

2.  Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Authors:  A W Tucker; A C Haddix; J S Bresee; R C Holman; U D Parashar; R I Glass
Journal:  JAMA       Date:  1998-05-06       Impact factor: 56.272

3.  European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary.

Authors:  Timo Vesikari; Pierre Van Damme; Carlo Giaquinto; Jim Gray; Jacek Mrukowicz; Ron Dagan; Alfredo Guarino; Hania Szajewska; Vytautas Usonis
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-05       Impact factor: 2.839

4.  Epidemiology and impact of rotavirus diarrhoea in Poland.

Authors:  J Z Mrukowicz; B Krobicka; M Duplaga; K Kowalska-Duplaga; J Domañski; H Szajewska; M Kantecki; F Iwañczak; T Pytrus
Journal:  Acta Paediatr Suppl       Date:  1999-01

5.  Epidemiology of rotavirus infections in The Netherlands.

Authors:  M Koopmans; I Van Asperen
Journal:  Acta Paediatr Suppl       Date:  1999-01

6.  Rotavirus infection among children with diarrhoea in Italy.

Authors:  F M Ruggeri; S Declich
Journal:  Acta Paediatr Suppl       Date:  1999-01

Review 7.  The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.

Authors:  H F Clark; P A Offit; R W Ellis; J J Eiden; D Krah; A R Shaw; M Pichichero; J J Treanor; F E Borian; L M Bell; S A Plotkin
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

8.  [Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group].

Authors:  B Laubereau; S Gateau; B Ehlken; K Huber; A Rohwedder; A Gervaix; U Heininger; U B Schaad
Journal:  Schweiz Med Wochenschr       Date:  1999-11-27

9.  Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000.

Authors:  Hwa-Gan H Chang; Roger I Glass; Perry F Smith; Helen G Cicirello; Robert C Holman; Dale L Morse
Journal:  Pediatr Infect Dis J       Date:  2003-09       Impact factor: 2.129

10.  Gastroenteritis by rotavirus in Spanish children. Analysis of the disease burden.

Authors:  Francisco Javier Luquero Alcalde; José María Eiros Bouza; Alberto Pérez Rubio; Maria Rosario Bachiller Luque; José Javier Castrodeza Sanz; Raúl Ortiz de Lejarazu Leonardo
Journal:  Eur J Pediatr       Date:  2007-07-25       Impact factor: 3.183

View more
  13 in total

1.  Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Authors:  Hiten D Patel; Eric T Roberts; Dagna O Constenla
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

Review 2.  Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? A rotavirus case study.

Authors:  Bernd Brüggenjürgen; Mathie Lorrot; Fiona R Sheppard; Vanessa Rémy
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  Burden of rotavirus infections in Liguria, Northern Italy: hospitalisations and potential savings by vaccination.

Authors:  D Panatto; D Amicizia; R Giacchino; A Tacchella; A R Natalizia; G Melioli; R Bandettini; P Di Pietro; M C Diana; R Gasparini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-04       Impact factor: 3.267

4.  Group A rotaviruses in children with gastroenteritis in a Canadian pediatric hospital: The prevaccine era.

Authors:  Estelle Chetrit; Yvan L'homme; Jagdip Singh Sohal; Caroline Quach
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

5.  Disease burden of rotavirus gastroenteritis in children up to 5 years of age in two Swiss cantons: paediatrician- and hospital-based surveillance.

Authors:  Laurence Lacroix; Annick Galetto-Lacour; Martin Altwegg; Konrad Egli; Martin Schmidt; Alain Gervaix
Journal:  Eur J Pediatr       Date:  2009-08-04       Impact factor: 3.183

6.  Recommendations for the use of rotavirus vaccines in infants.

Authors:  Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2017-06-30       Impact factor: 2.253

7.  Epidemiological studies on gastroenteritis in children in the Bannu district, Khyber Pakhtunkhwa, Pakistan.

Authors:  Muhammad Ashraf Khan
Journal:  Z Gesundh Wiss       Date:  2021-05-21

8.  Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.

Authors:  Patricia Bruijning-Verhagen; Marie-Josée J Mangen; Mariet Felderhof; Nico G Hartwig; Marlies van Houten; Léon Winkel; Wouter J de Waal; Marc J M Bonten
Journal:  BMC Med       Date:  2013-04-26       Impact factor: 8.775

9.  Impact of self-financed rotavirus vaccines on hospital stays and costs in Spain after a 3-year introductory period.

Authors:  O Redondo-González; J M Tenías-Burillo; J Ruiz-Gonzalo
Journal:  Epidemiol Infect       Date:  2017-04-03       Impact factor: 4.434

10.  Socio-demographic, Clinical and Laboratory Features of Rotavirus Gastroenteritis in Children Treated in Pediatric Clinic.

Authors:  Mehmedali Azemi; Majlinda Berisha; Vlora Ismaili-Jaha; Selim Kolgeci; Muharrem Avdiu; Xhevat Jakupi; Rina Hoxha; Teuta Hoxha-Kamberi
Journal:  Mater Sociomed       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.